5748 Inorganic Chemistry, Vol. 39, No. 25, 2000
Cohen et al.
CH2), 3.08 (q, J ) 6.0 Hz, 4H, CH2), 3.24 (q, J ) 5.8 Hz, 2H, CH2),
3.57 (s, 6H, NCH3), 5.04 (s, 2H, CH2), 5.27 (s, 4H, CH2), 6.66 (d, J )
7.2 Hz, 2H, Ar H), 6.96 (d, J ) 8.2 Hz, 1H, Ar H), 7.05 (d, J ) 7.2
Hz, 2H, Ar H), 7.30 (m, 17H, Ar H), 7.76 (t, J ) 5.2 Hz, 2H, NH),
7.85 (br t, 1H, NH), 8.11 (d, J ) 6.0 Hz, 1H, Ar H). 13C NMR (400
MHz, CDCl3, 25 °C): δ 34.0, 37.2, 37.6, 37.7, 52.0, 52.2, 71.2, 74.7,
104.7, 112.7, 121.4, 121.9, 127.8, 128.6, 128.7, 128.8, 129.0, 130.8,
132.1, 132.2, 132.4, 135.8, 136.3, 146.2, 156.6, 159.5, 163.3, 165.2.
Anal. Calcd (found) for C48H50N6O8‚2H2O: C, 65.89 (66.13); H, 6.22
(5.93); N, 9.60 (9.97). (+)-FABMS: m/z 839 [M+ + H].
TREN-Me-3,2-HOPOSAM (2). 1 (1.8 mmol) was dissolved in 40
mL of 1:1 concentrated HCl/glacial acetic acid. After 18 h of stirring,
the solution was evaporated to dryness. The residue was coevaporated
with 4 × 20 mL of MeOH and then oven-dried, giving a pale yellow
solid. Yield: 79%. IR (KBr pellet): ν 1540, 1594, 3255 cm-1. 1H NMR
(300 MHz, CD3OD, 25 °C): δ 3.35 (s, 6H, NCH3), 3.59 (br s, 6H,
CH2), 3.76 (br s, 6H, CH2), 6.18 (br s, 2H, Ar H), 6.62 (br s, 2H, Ar
H), 6.71 (d, J ) 7.2 Hz, 2H, Ar H), 7.17 (br t, 1H, Ar H), 7.47 (br d,
1H, Ar H). 13C NMR (400 MHz, DMSO-d6, 25 °C): δ 34.4, 37.1,
52.1, 75.3, 103.0, 115.5, 116.6, 117.5, 119.0, 127.9, 128.5, 134.1, 148.0,
158.3, 159.8, 166.9, 169.8. Anal. Calcd (found) for C27H33N6O8Cl‚
MeOH‚0.5HCl: C, 51.32 (51.24); H, 5.77 (5.58); N, 12.82 (12.55).
(+)-FABMS: m/z 569 [M+ + H].
Figure 1. Diagram of the ligands examined in this study. The ligands
are designated TREN-Me-3,2-HOPO- followed by the suffixes indicated
in the figure.
This work details the syntheses of heteropodands that possess
sites for facile functionalization (Figure 1). These ligands use
an (Me-3,2-HOPO)-substituted TREN compound as an universal
intermediate. The syntheses, solution thermodynamics, and
relaxivity properties of these systems are described. The results
indicate that three of the ligand systems described have
properties desirable for new MRI imaging agents, including high
relaxivity and thermodynamic stability. Among the most notable
attributes is an extremely rapid water exchange rate (30-100
ns) that makes these complexes amenable to incorporation into
macromolecular structures. The rapid water exchange rate is
due to a low-energy barrier between the 8- and 9-coordinate
metal complexes. This hypothesis is supported by the crystal
structure of La[TREN-Me-3,2-HOPO], which shows both
coordination numbers at the metal ion in the same unit cell.
The findings suggest that an HOPO-based heteropodand ligand
strategy has substantial promise for designing MRI contrast
agents.
TREN-Me-3,2-HOPOBAC (3). (3,2-HOPO)2TREN9 (3.2 mmol),
benzyl 2-bromoacetate (10 mmol), and anhydrous K2CO3 (10 mmol)
were combined in dry THF (50 mL). The stirred mixture was warmed
to 60 °C overnight under N2(g). After the system had cooled to room
temperature, the reaction mixture was filtered, the filtrate was rotary-
evaporated, and the residue was applied to a flash silica gel column.
Elution with 0.5-4.0% CH3OH in CH2Cl2 produced a pale yellow,
thick oil as the pure benzyl-protected precursor. The ligand was
immediately deprotected by dissolving the protected precursor in glacial
acetic acid (20 mL) containing 20% Pd(OH)2 on charcoal catalyst (200
mg). The mixture was stirred under an atmosphere of H2(g) (400 psi)
at room temperature overnight. The solution was filtered, and the filtrate
was evaporated to dryness, affording a pale brown residue. The residue
was recrystallized from methanol to give 3 as a white powder. Yield:
53%. 1H NMR (500 MHz, D2O, 25 °C): δ 3.29 (br s, 4H, CH2), 3.37
(s, 6H, CH2), 3.40-3.42 (br m, 2H, CH2), 3.54 (br s, 4H, CH2), 3.79
(s, 6H, NCH3), 6.351 (d, J ) 4.3 Hz, 2H, Ar H), 6.839 (d, J ) 4.3 Hz,
2H, Ar H). 13C NMR (500 MHz, DMSO-d6, 25 °C): ν 36.33, 36.85,
51.08, 51.68, 55.77, 102.55, 116.67, 127.43, 148.12, 158.05, 165.83,
172.26. (+)-FABMS: m/z 565 [M+ + H]. Anal. Calcd (found) for
C24H32N6O10‚1.2H2O: C, 49.17 (49.68); H, 5.91 (6.15); N, 14.33
(13.98).
Experimental Section
Syntheses. General Information. Unless otherwise noted, starting
materials were obtained from commercial suppliers and used without
further purification. Tris(2-aminoethyl)amine was distilled under
vacuum from CaH2. Flash silica gel chromatography was performed
using Merck 40-70 mesh silica gel. Microanalyses were performed at
the Microanalytical Services Laboratory, College of Chemistry, Uni-
versity of California, Berkeley. Mass spectra were recorded at the Mass
Spectrometry Laboratory, College of Chemistry, University of Cali-
fornia, Berkeley. All NMR spectra were recorded either on an AMX
300 or 400 Bruker superconducting Fourier transform spectrometer or
on a DRX 500 Bruker superconducting digital spectrometer. Infrared
spectra were obtained using a Nicolet Magna IR 550 Fourier transform
spectrometer. The syntheses of the terephthalamide heteropodand,
TREN-Me-3,2-HOPOTAM, and the isophthalamide heteropodand,
TREN-Me-3,2-HOPOIAM, are described elsewhere.9
Protected TREN-Me-3,2-HOPOSAM (1). (3,2-HOPO)2TREN9 (2.2
mmol) was dissolved in 70 mL of dry CH2Cl2. This solution was added
to a solution of 2-(benzyoxybenzoyl)succinimide (2.6 mmol) dissolved
in 30 mL of dry CH2Cl2. After 2 h, the resulting solution was evaporated
to dryness, affording an amber oil. The oil was purified by silica column
chromatography with 0-8% MeOH in CH2Cl2 as the eluant. Removal
of solvent gave the product as a white foam. Yield: 78%. IR (film
from CH2Cl2): ν 1538, 1645, 3384 cm-1. 1H NMR (300 MHz, CDCl3,
25 °C): δ 2.25 (t, J ) 6.7 Hz, 4H, CH2), 2.36 (t, J ) 6.5 Hz, 2H,
HGd[TREN-Me-3,2-HOPOTAM]. TREN-Me-3,2-HOPOTAM (0.10
mmol) was dissolved in 10 mL of MeOH. Gd(NO3)3‚6H2O (0.10 mmol)
was added to the methanol solution, followed by an excess of pyridine,
which caused the precipitation of an off-white solid. The mixture was
heated to reflux for 2 h and was then evaporated to dryness. The residue
i
was then suspended in PrOH. This was followed by sonication, and
filtration to give the acid complex final product. (-)-FABMS: m/z
795 [M-].
Gd[TREN-Me-3,2-HOPOIAM]. TREN-Me-3,2-HOPOIAM (0.10
mmol) was dissolved in 10 mL of MeOH. Gd(NO3)3‚6H2O (0.10 mmol)
was added to the methanol solution, followed by an excess of pyridine.
The mixture was heated to reflux for 2 h and was then evaporated to
dryness. The residue was suspended in iPrOH, followed by sonication
and filtration. (+)-FABMS: m/z 781 [M+ + H].
Gd[TREN-Me-3,2-HOPOSAM]. 2 (0.20 mmol) was dissolved in
10 mL of MeOH. Gd(NO3)3‚6H2O (0.20 mmol) was added to the
methanol solution, followed by an excess of pyridine, which caused
the precipitation of an off-white solid. The mixture was refluxed for 2
h and was then evaporated to dryness. The residue was suspended in
iPrOH, followed by sonication and filtration. (+)-FABMS: m/z 724
[M+ + H].
KGd[TREN-Me-3,2-HOPOBAC]. To a solution of 3 (0.20 mmol)
in dry methanol (20 mL) was added 4 equiv of KOH solution in
methanol (0.1027 N) to neutralize the ligand. A solution of GdCl3‚
6H2O (0.18 mmol) in methanol (10 mL) was added slowly to the ligand
solution with stirring. The mixture was heated to reflux for 6 h under
(9) Cohen, S. M.; O’Sullivan, B.; Raymond, K. N. Inorg. Chem., in press.